
The Division of Stem Cell Transplantation and Cellular Therapies at Dana-Farber Brigham Cancer Center has been a leader in cellular therapies since our program's founding in 1972. Our stem cell transplantation program is one of the largest and most experienced transplant centers in the world, with outcomes that consistently exceed expected outcomes established by the Center for International Blood and Marrow Transplant Research (CIBMTR). Our program is also at the forefront of emerging cellular therapies that help the immune system fight cancer such as CAR T-cell therapy, cancer vaccines, NK cell therapy, and genetically-modified immune cells.